The fibrinolytic enzyme system in obesity: the effects of venous occlusion and in vitro activation by surface contact.
D000328:Adult; D000933:Antifibrinolytic Agents / Q000097:blood; D001778:Blood Coagulation Disorders / Q000201:enzymology / Q000209:etiology* / Q000628:therapy; D001780:Blood Coagulation Tests; D005174:Factor XII / Q000032:analysis; D005260:Female; D005342:Fibrinolysis / Q000187:drug effects; D005343:Fibrinolytic Agents / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008722:Methods; D009765:Obesity / Q000097:blood* / Q000201:enzymology; D013299:Streptodornase and Streptokinase / Q000097:blood; D013499:Surface Properties
D000933:Antifibrinolytic Agents; D005343:Fibrinolytic Agents; D005174:Factor XII; D013299:Streptodornase and Streptokinase